These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 10829805)

  • 21. Heterogeneity of white matter hyperintensities in Alzheimer's disease: post-mortem quantitative MRI and neuropathology.
    Gouw AA; Seewann A; Vrenken H; van der Flier WM; Rozemuller JM; Barkhof F; Scheltens P; Geurts JJ
    Brain; 2008 Dec; 131(Pt 12):3286-98. PubMed ID: 18927145
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Does magnetization transfer ratio (MTR) contribute to the diagnosis and differential diagnosis of the dementias?].
    Hentschel F; Kreis M; Damian M; Krumm B
    Rofo; 2004 Dec; 176(12):1743-9. PubMed ID: 15573284
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Auditory sensory memory and the cholinergic system: implications for Alzheimer's disease.
    Pekkonen E; Hirvonen J; Jääskeläinen IP; Kaakkola S; Huttunen J
    Neuroimage; 2001 Aug; 14(2):376-82. PubMed ID: 11467911
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The neural correlates of verbal short-term memory in Alzheimer's disease: an fMRI study.
    Peters F; Collette F; Degueldre C; Sterpenich V; Majerus S; Salmon E
    Brain; 2009 Jul; 132(Pt 7):1833-46. PubMed ID: 19433442
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Altered response to rTMS in patients with Alzheimer's disease.
    Inghilleri M; Conte A; Frasca V; Scaldaferri N; Gilio F; Santini M; Fabbrini G; Prencipe M; Berardelli A
    Clin Neurophysiol; 2006 Jan; 117(1):103-9. PubMed ID: 16364684
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Behaviour of free radicals in Alzheimer's disease].
    Terranova R; Sorace R; Romeo A; Di Mauro C; Romeo R; Luca S
    Minerva Med; 2001 Dec; 92(6):405-10. PubMed ID: 11740427
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Motor cortex excitability in Alzheimer's disease and in subcortical ischemic vascular dementia.
    Alagona G; Ferri R; Pennisi G; Carnemolla A; Maci T; Domina E; Maertens de Noordhout A; Bella R
    Neurosci Lett; 2004 May; 362(2):95-8. PubMed ID: 15193762
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurogenic vestibular evoked potentials using a tone pip auditory stimulus.
    Papathanasiou ES; Zamba-Papanicolaou E; Pantziaris M; Kleopas K; Kyriakides T; Papacostas S; Pattichis C; Iliopoulos I; Piperidou C
    Electromyogr Clin Neurophysiol; 2004; 44(3):167-73. PubMed ID: 15125057
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Navigated TMS combined with EEG in mild cognitive impairment and Alzheimer's disease: a pilot study.
    Julkunen P; Jauhiainen AM; Westerén-Punnonen S; Pirinen E; Soininen H; Könönen M; Pääkkönen A; Määttä S; Karhu J
    J Neurosci Methods; 2008 Jul; 172(2):270-6. PubMed ID: 18533272
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Electrophysiological changes in patients with early stages of Alzheimer's disease].
    Krasodomska K; Lubiński W; Potemkowski A; Honczarenko K; Gołab-Janowska M; Ratajczak M; Szych Z
    Ann Acad Med Stetin; 2007; 53 Suppl 1():49-57; discussion 57. PubMed ID: 19425480
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic value of event-related evoked potentials N200 and P300 subcomponents in early diagnosis of Alzheimer's disease and mild cognitive impairment.
    Bennys K; Portet F; Touchon J; Rondouin G
    J Clin Neurophysiol; 2007 Oct; 24(5):405-12. PubMed ID: 17912065
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence and severity of gait disorders in Alzheimer's and non-Alzheimer's dementias.
    Allan LM; Ballard CG; Burn DJ; Kenny RA
    J Am Geriatr Soc; 2005 Oct; 53(10):1681-7. PubMed ID: 16181166
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regional brain activity after prolonged cholinergic enhancement in early Alzheimer's disease.
    Shanks MF; McGeown WJ; Forbes-McKay KE; Waiter GD; Ries M; Venneri A
    Magn Reson Imaging; 2007 Jul; 25(6):848-59. PubMed ID: 17442521
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evoked potentials in the assessment of brain function in senile dementia.
    Laurian S; Gaillard JM; Wertheimer J
    Adv Neurol; 1982; 32():287-93. PubMed ID: 7054951
    [No Abstract]   [Full Text] [Related]  

  • 35. [Interhemispheric asymmetry and neuroimmune modulation in normal aging and Alzheimer's-type dementias].
    Fokin VF; Ponomareva NV; Androsova LV; Gavrilova SI
    Fiziol Cheloveka; 1997; 23(3):20-4. PubMed ID: 9264942
    [No Abstract]   [Full Text] [Related]  

  • 36. [Geriatric medicine in future].
    Kameyama M
    Nihon Ronen Igakkai Zasshi; 1989 Jan; 26(1):1-10. PubMed ID: 2671448
    [TBL] [Abstract][Full Text] [Related]  

  • 37. P300 and Alzheimer's disease.
    Polich J
    Biomed Pharmacother; 1989; 43(7):493-9. PubMed ID: 2684293
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Psycho-geriatric evaluation of Alzheimer's disease: from neurologic deficiencies to social handicaps].
    Bonhomme P
    Rev Infirm; 1995 Nov; (17):23-30. PubMed ID: 8900642
    [No Abstract]   [Full Text] [Related]  

  • 39. Alzheimer's disease: an age-old problem.
    Rousseau PC
    Hosp Pract (Off Ed); 1987 Jan; 22(1):163, 166, 168 passim. PubMed ID: 3098766
    [No Abstract]   [Full Text] [Related]  

  • 40. Screening patients for Alzheimer's disease.
    Cross PL
    Br J Gen Pract; 1994 Jun; 44(383):283. PubMed ID: 8037988
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.